Camber Announces Six New Product Launches
Camber Pharmaceuticals, one of the industry’s fastest growing generic pharmaceutical companies is pleased to announce the addition of six new products to its rapidly expanding product line.
Quinapril HCTZ Naproxen Levetiracetam
– 10/12.5mg/90ct – 250mg/100ct and 500ct – 250mg/ 120ct and 500ct – 1000mg/ 60ct
– 20/12.5mg/90ct – 375mg/ 100ct and 500ct – 500mg/120ct and 500ct
– 20/25mg/90ct – 500mg/ 100ct and 500ct – 750mg/120ct and 500ct
Quinapril Naproxen DR Alfuzosin
– 5mg/90ct – 375mg/100ct – 10mg/100ct
– 10mg/90ct – 500mg/100ct
– 20mg/90ct – 500mg/500ct
– 40mg/90ct
Camber Pharmaceuticals is a fully integrated international pharmaceutical company that maintains quality and integrity in all its products from API manufacturing to finished dosage. Camber’s parent company Hetero Drugs of Hyderabad, India employs over 300 scientists at 9 API facilities and has a global presence in over 100 countries.
Recent articles
- Camber Launches 13 New Generic Products in Q1 2025, Sets Ambitious Pace for the Year
- Camber Launches Mycophenolate Mofetil Capsules
- Camber Launches Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral Solution
- Camber’s Triple Play – Featured Generics
- Big Game Commercial
- Charting a Bold Path for 2025